研究者総覧 - 大森　翔太

オオモリ　ショウタ
大森　翔太

所属大分大学医学部臨床医学・呼吸器・感染症内科学

職種助教

論文
論文	Correlation between cancer cachexia and psychosocial impact in older patients with advanced lung cancer undergoing chemotherapy Asia-Pacific Journal of Oncology Nursing 12,100658-100658頁 2025/12
論文	呼吸器内科医によるCyto-Quick染色法を用いた迅速細胞診(ROSE)の後方視的検討肺癌 65 (5),531-531頁 2025/11
論文	呼吸器内科医によるCyto-Quick染色法を用いた迅速細胞診(ROSE)の後方視的検討肺癌 65 (5),531-531頁 2025/11
論文	放射線肺炎に対するステロイドパルス療法の意義 DPCデータを用いた後方視的研究肺癌 65 (5),711-711頁 2025/11
論文	放射線肺炎に対するステロイドパルス療法の意義 DPCデータを用いた後方視的研究肺癌 65 (5),711-711頁 2025/11
論文	Atezolizumab with carboplatin plus nab-paclitaxel combination therapy for TTF-1 negative advanced nonsquamous non–small cell lung cancer: A multicenter, single-arm phase 2 trial (F1NE TUNE, LOGiK 2102) European Journal of Cancer 229,115779-115779頁 2025/10
論文	Role of Antipseudomonal Antibiotics in Older Patients with Aspiration Pneumonia: A Nationwide Database Study in Japan Antibiotics 14 (8) 2025/07/24
論文	Phase II study of afatinib for advanced non-small cell lung cancer with uncommon epidermal growth factor receptor mutations, including compound mutations detected by next-generation sequencing International Journal of Clinical Oncology 30 (9),1787-1796頁 2025/07/06
論文	Platinum plus etoposide with durvalumab for extensive-stage small-cell lung cancer with untreated brain metastases: a multicenter, single-arm phase II trial (LOGiK2001, SPEED) ESMO Open 10 (7),105325-105325頁 2025/07
論文	Desensitizing Effect of Intra‐Tumoral <scp>GDF</scp>‐15 on Immunotherapy in Patients With Advanced Non‐Small Cell Lung Cancer Thoracic Cancer 16 (10),e70089 2025/05/21
論文	間質性肺炎の治療中に気管支肺胞洗浄で診断した自己免疫性肺胞蛋白症の1例気管支学 47 (Suppl.),S288-S288頁 2025/05
論文	気管支鏡で敷石像変化を認めたCOVID-19関連肺アスペルギルス症の1例気管支学 47 (Suppl.),S235-S235頁 2025/05
論文	DPCデータを用いた気管支拡張症の肺炎または増悪に対する抗緑膿菌活性抗菌薬投与群における予後因子の検討日本感染症学会総会・学術講演会・日本化学療法学会学術集会合同学会プログラム・抄録集 99回・73回,O-062頁 2025/04
論文	Cyto-Quick法を用いた迅速細胞診(ROSE)の実施経験気管支学 47 (2),183-184頁 2025/03
論文	DPCデータを用いた高齢者誤嚥性肺炎に関する検討日本呼吸器学会誌 14 (増刊),365-365頁 2025/03
論文	Impact of Antipseudomonal Antibiotics in Patients with Bronchiectasis Who Experienced Exacerbation or Developed Pneumonia: A Nationwide Study in Japan. Antibiotics (Basel, Switzerland) 13 (12) 2024/12/05
論文	Comparison of High-Dose versus Low-Dose Trimethoprim–Sulfamethoxazole for Treating Pneumocystis jirovecii Pneumonia among Hemodialysis Patients: A Nationwide Database Study in Japan Journal of Clinical Medicine 13 (18) 2024/09/14
論文	Suitability of frozen cell pellets from cytology specimens for the <scp>A</scp>moy 9‐in‐1 assay in patients with non‐small cell lung cancer Thoracic Cancer 15 (21),1665-1672頁 2024/06/19
論文	Medical Causes of Hospitalisation among Patients with Bronchiectasis: A Nationwide Study in Japan Pathogens 13 (6) 2024/06/09
論文	Efficacy of second-line chemotherapy in patients with pulmonary large cell neuroendocrine carcinoma Scientific Reports 14 (1),7641-7641頁 2024/04/01
論文	Lung Injury Induced by Crizotinib and Entrectinib in a Patient with ROS1-rearranged Non-small-cell Lung Cancer. Internal medicine (Tokyo, Japan) 62 (23),3507-3510頁 2023/12/01
論文	Immunohistochemical analysis of B7-H3 expression in patients with lung cancer following various anti-cancer treatments. Investigational new drugs 41 (2),356-364頁 2023/04
論文	Acute eosinophilic pneumonia in twins. Respiratory investigation 61 (1),1-4頁 2023/01
論文	Clinical impact of tumour burden on the efficacy of PD‐1/PD‐L1 inhibitors plus chemotherapy in non‐small‐cell lung cancer Cancer Medicine 12 (2),1451-1460頁 2023/01
論文	Incidence and treatment outcome of radiation pneumonitis in limited-stage small-cell lung cancer patients treated with concurrent accelerated hyperfractionated radiotherapy and chemotherapy Advances in Radiation Oncology 8 (2),101129-101129頁 2022/11
論文	Trophoblast cell-surface antigen 2 expression in lung cancer patients and the effects of anti-cancer treatments. Journal of cancer research and clinical oncology 148 (9),2455-2463頁 2022/09
論文	Exploring the educational needs for severe immune-related adverse events of PD-1/PD-L1 inhibitors in advanced lung cancer: A single-center observational study Asia-Pacific Journal of Oncology Nursing 9 (8),100076-100076頁 2022/08
論文	Prospective evaluation of the relationship between response and exposure of total and unbound erlotinib in non-small cell lung cancer patients. Cancer chemotherapy and pharmacology 90 (2),115-123頁 2022/07/11
論文	Predicting the efficacy of first‐line immunotherapy by combining cancer cachexia and tumor burden in advanced non‐small cell lung cancer Thoracic Cancer 13 (14),2064-2074頁 2022/07
論文	Multi-institutional feasibility study of intensity-modulated radiotherapy with chemotherapy for locally advanced non-small cell lung cancer. International journal of clinical oncology 27 (6),1025-1033頁 2022/06
論文	Impact of losing adipose tissue on outcomes from PD ‐1/ PD‐L1 inhibitor monotherapy in non‐small cell lung cancer Thoracic Cancer 13 (10),1496-1504頁 2022/05
論文	Correction to: Prognostic impact of pneumonitis after durvalumab therapy in patients with locally advanced non‑small cell lung cancer. Investigational new drugs 40 (2),464-464頁 2022/04
論文	Impact of weight loss on treatment with PD-1/PD-L1 inhibitors plus chemotherapy in advanced non-small-cell lung cancer Supportive Care in Cancer 30 (2),1633-1641頁 2022/02
論文	Phase I study of weekly nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in elderly patients with unresectable locally advanced non-small cell lung cancer. Investigational new drugs 40 (1),106-114頁 2022/02
論文	Real-world data on NGS using the Oncomine DxTT for detecting genetic alterations in non-small-cell lung cancer: WJOG13019L. Cancer science 113 (1),221-228頁 2022/01
論文	Phase 1b study of ramucirumab in combination with irinotecan plus cisplatin in chemo-naive patients with extensive-stage small-cell lung cancer Lung Cancer 164,39-45頁 2022
論文	A Randomized Phase 2 Study Comparing Nivolumab with Carboplatin-Pemetrexed for EGFR-Mutated NSCLC with Resistance to EGFR Tyrosine Kinase Inhibitors (WJOG8515L). Clinical cancer research : an official journal of the American Association for Cancer Research 28 (5),893-902頁 2021/12/17
論文	Comparison of clinical features between immune-related sclerosing cholangitis and hepatitis. Investigational new drugs 39 (6),1716-1723頁 2021/12
論文	Long-term outcomes in extensive disease small cell lung cancer patients treated without immune checkpoint inhibitors JAPANESE JOURNAL OF CLINICAL ONCOLOGY 51 (12),1736-1743頁 2021/12
論文	Rechallenge with previously administered epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer with leptomeningeal metastasis. Investigational new drugs 39 (6),1732-1741頁 2021/12
論文	Impact of angiogenesis inhibitor eligibility on the prognosis of patients with non-small cell lung cancer harboring EGFR mutation. Cancer medicine 10 (21),7503-7513頁 2021/11
論文	Long-term survival data of patients with limited disease small cell lung cancer: a retrospective analysis. Investigational new drugs 40 (2),411-419頁 2021/10/30
論文	耐性化したEGFR遺伝子変異陽性非小細胞肺癌に対するNivolumabとCBDCA+PEMの第2相比較臨床試験(WJOG8515L) 肺癌 61 (6),677-677頁 2021/10
論文	Effect of Second-generation vs Third-generation Chemotherapy Regimens With Thoracic Radiotherapy on Unresectable Stage III Non-Small-Cell Lung Cancer: 10-Year Follow-up of a WJTOG0105 Phase 3 Randomized Clinical Trial. JAMA oncology 7 (6),904-909頁 2021/06/01
論文	Correction to: Clinical and radiation dose-volume factors related to pneumonitis after treatment with radiation and durvalumab in locally advanced non-small cell lung cancer. Investigational new drugs 39 (3),899-899頁 2021/06
論文	Impact of prior ALK-tyrosine kinase inhibitor on pemetrexed-based chemotherapy in patients with advanced ALK positive non-small cell lung cancer. JOURNAL OF CLINICAL ONCOLOGY 39 (15) 2021/05
論文	A multi-institutional randomized phase III study comparing weekly carboplatin plus nab-paclitaxel and daily low-dose carboplatin as regimens for concurrent chemoradiotherapy in elderly patients with unresectable locally advanced non-small cell lung cancer: Japan Clinical Oncology Group Study JCOG1914. Japanese journal of clinical oncology 51 (5),836-841頁 2021/04/30
論文	Detection of programmed cell death-ligand 1 using 22C3 antibody in patients with unresectable stage III non-small cell lung cancer receiving chemoradiotherapy. International journal of clinical oncology 26 (4),659-669頁 2021/04
論文	Retrospective analysis of osimertinib re-challenge after osimertinib-induced interstitial lung disease in patients with EGFR-mutant non-small cell lung carcinoma. Investigational new drugs 39 (2),571-577頁 2021/04
論文	Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities. Radiation oncology (London, England) 16 (1),52-52頁 2021/03/17
論文	Cumulative incidence of venous thromboembolism in patients with advanced cancer in prospective observational study Cancer Medicine 10 (3),895-904頁 2021/02
論文	Clinical impact of walking capacity on the risk of disability and hospitalizations among elderly patients with advanced lung cancer. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 29 (7),3961-3970頁 2021/01/03
論文	Efficacy of pembrolizumab in patients with brain metastasis caused by previously untreated non-small cell lung cancer with high tumor PD-L1 expression LUNG CANCER 151,60-68頁 2021/01
論文	Unfavorable impact of decreased muscle quality on the efficacy of immunotherapy for advanced non‐small cell lung cancer Cancer Medicine 10 (1),247-256頁 2021/01
論文	Association between oligo-residual disease and patterns of failure during EGFR-TKI treatment in EGFR-mutated non-small cell lung cancer: a retrospective study BMC Cancer (Web) 21 (1),1247-1247頁 2021
論文	Proposing synchronous oligometastatic non-small-cell lung cancer based on progression after first-line systemic therapy. Cancer science 112 (1),359-368頁 2020/10/23
論文	Clinical and radiation dose-volume factors related to pneumonitis after treatment with radiation and durvalumab in locally advanced non-small cell lung cancer. Investigational new drugs 38 (5),1612-1617頁 2020/10
論文	Association Between Clinical Tumor Burden and Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer. Clinical lung cancer 21 (5),e405-e414 2020/09
論文	PD-L1 expression and response to pembrolizumab in patients with EGFR-mutant non-small cell lung cancer. Japanese journal of clinical oncology 50 (5),617-622頁 2020/05/05
論文	Evaluation of gefitinib systemic exposure in EGFR-mutated non-small cell lung cancer patients with gefitinib-induced severe hepatotoxicity. Cancer chemotherapy and pharmacology 85 (3),605-614頁 2020/03
論文	Negative impact of malignant effusion on osimertinib treatment for non-small cell lung cancer harboring EGFR mutation. Investigational new drugs 38 (1),194-201頁 2020/02
論文	Desensitizing effect of cancer cachexia on immune checkpoint inhibitors in patients with advanced non-small-cell lung cancer JTO Clinical and Research Reports 1 (2),100020-100020頁 2020
論文	Efficacy of Second-line Chemotherapy in Patients With Sensitive Relapsed Small-cell Lung Cancer IN VIVO 33 (6),2229-2234頁 2019/11
論文	Acquired immunodeficiency associated with thymoma: a case report. BMC cancer 19 (1),762-762頁 2019/08/02
論文	Optimal Sequence of Local and EGFR-TKI Therapy for EGFR-Mutant Non-Small Cell Lung Cancer With Brain Metastases Stratified by Number of Brain Metastases. International journal of radiation oncology, biology, physics 104 (3),604-613頁 2019/07/01
論文	The impact of steroid use on efficacy of immunotherapy among patients with lung cancer who have developed immune-related adverse events. JOURNAL OF CLINICAL ONCOLOGY 37 (15) 2019/05
論文	Corrigendum to "Genetic alterations of driver genes as independent prognostic factors for disease-free survival in patients with resected non-small cell lung cancer" [Lung Cancer 128 (2019) 152-157]. Lung cancer (Amsterdam, Netherlands) 130,226-226頁 2019/04
論文	Genetic alterations of driver genes as independent prognostic factors for disease-free survival in patients with resected non-small cell lung cancer LUNG CANCER 128,152-157頁 2019/02
論文	Leptomeningeal recurrence after long-term alectinib therapy for non-small cell lung cancer harboring an EML4-ALK fusion protein. Investigational new drugs 37 (1),184-187頁 2019/02
論文	Platinum Combination Chemotherapy Is Poorly Tolerated in Malnourished Advanced Lung Cancer Patients with Poor Performance Status. Nutrition and cancer 71 (5),767-771頁 2019
論文	Changes in programmed death ligand 1 expression in non-small cell lung cancer patients who received anticancer treatments. International journal of clinical oncology 23 (6),1052-1059頁 2018/12
論文	Gefitinib-Induced Cardiomyopathy in Epidermal Growth Receptor-Mutated NSCLC. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 13 (10),e207-e208 2018/10
論文	Efficacy of second-line chemotherapy in poor-risk patients with refractory-relapsed small-cell lung cancer JAPANESE JOURNAL OF CLINICAL ONCOLOGY 48 (9),822-826頁 2018/09
論文	ILD-NSCLC-GAP index scoring and staging system for patients with non small cell lung cancer and interstitial lung disease LUNG CANCER 121,48-53頁 2018/07
論文	Efficacy of prophylactic cranial irradiation in patients with limited-disease small-cell lung cancer who were confirmed to have no brain metastasis via magnetic resonance imaging after initial chemoradiotherapy Oncotarget 9 (25),17664-17674頁 2018/04
論文	Clinical Factors Predicting Detection of T790M Mutation in Rebiopsy for EGFR-Mutant Non-small-cell Lung Cancer CLINICAL LUNG CANCER 19 (2),E247-E252頁 2018/03
論文	CYFRA 21-1 predicts the efficacy of nivolumab in patients with advanced lung adenocarcinoma Tumor Biology 40 (2),1010428318760420-1010428318760420頁 2018/02/01
論文	Impact of Interstitial Lung Disease Classification on the Development of Acute Exacerbation of Interstitial Lung Disease and Prognosis in Patients with Stage III Non-Small-Cell Lung Cancer and Interstitial Lung Disease Treated With Chemoradiotherapy JOURNAL OF CANCER 9 (11),2054-2060頁 2018
論文	The effects of advanced age and serum α1 -acid glycoprotein on docetaxel unbound exposure and dose-limiting toxicity in cancer patients. British journal of clinical pharmacology 83 (11),2416-2425頁 2017/11
論文	Unfavorable impact of cancer cachexia on activity of daily living and need for inpatient care in elderly patients with advanced non-small-cell lung cancer in Japan: a prospective longitudinal observational study BMC CANCER 17 (1),800-800頁 2017/11
論文	Modified GAP index for prediction of acute exacerbation of idiopathic pulmonary fibrosis in non-small cell lung cancer. Respirology (Carlton, Vic.) 22 (7),1379-1385頁 2017/10
論文	A Phase II study of palonosetron, aprepitant, dexamethasone and olanzapine for the prevention of cisplatin-based chemotherapy-induced nausea and vomiting in patients with thoracic malignancy. Japanese journal of clinical oncology 47 (9),840-843頁 2017/09/01
論文	Survival data for postoperative adjuvant chemotherapy comprising cisplatin plus vinorelbine after complete resection of non-small cell lung cancer. Cancer chemotherapy and pharmacology 80 (3),609-614頁 2017/09
論文	Response to the treatment immediately before nivolumab monotherapy may predict clinical response to nivolumab in patients with non-small cell lung cancer. International journal of clinical oncology 22 (4),690-697頁 2017/08
論文	Skeletal muscle depletion during chemotherapy has a large impact on physical function in elderly Japanese patients with advanced non-small-cell lung cancer BMC CANCER 17 (1),571-571頁 2017/08
論文	The incidence and risk factors of febrile neutropenia in chemotherapy-naive lung cancer patients receiving etoposide plus platinum CANCER CHEMOTHERAPY AND PHARMACOLOGY 79 (6),1229-1237頁 2017/06
論文	Amrubicin monotherapy may be an effective second-line treatment for patients with large-cell neuroendocrine carcinoma or high-grade non-small-cell neuroendocrine carcinoma. Molecular and clinical oncology 6 (5),718-722頁 2017/05
論文	Impact of early progression on prognosis for non-small cell lung cancer patients with EGFR mutation. JOURNAL OF CLINICAL ONCOLOGY 35 2017/05
論文	Plasma epidermal growth factor receptor mutation testing with a chip-based digital PCR system in patients with advanced non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 106,138-144頁 2017/04
論文	Doublet chemotherapy with cisplatin and pemetrexed is associated with a favorable outcome in patients with advanced non-squamous non-small-cell lung cancer who are eligible for bevacizumab and maintenance therapy. Molecular and clinical oncology 5 (5),575-578頁 2016/11
論文	Rebiopsy for patients with non-small-cell lung cancer after epidermal growth factor receptor-tyrosine kinase inhibitor failure. Cancer science 107 (7),1001-5頁 2016/07
論文	Organizing Pneumonia Induced by Nivolumab in a Patient with Metastatic Melanoma. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 11 (3),432-3頁 2016/03
論文	The effect of gefitinib in patients with postoperative recurrent non-small cell lung cancer harboring mutations of the epidermal growth factor receptor. International journal of clinical oncology 20 (4),668-73頁 2015/08